We are live on
!
Find out more
B
BP Portfolio holdings
AUM
$17.7M
1-Year Est. Return
12.34%
This Fund
S&P 500
This Quarter
Est. Return
+10.44%
1 Year Est. Return
+12.34%
3 Year Est. Return
+57.04%
5 Year Est. Return
+25.97%
10 Year Est. Return
+282.85%
AUM
$2.97B
AUM Growth
+$269M
(+10%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
555
New
36
Increased
72
Reduced
56
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$11.1M |
| 2 |
Alibaba
BABA
|
+$8.02M |
| 3 |
NVIDIA
NVDA
|
+$5.6M |
| 4 |
AbbVie
ABBV
|
+$5.4M |
| 5 |
Walt Disney
DIS
|
+$5.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$11.1M |
| 2 |
McDonald's
MCD
|
+$5.55M |
| 3 |
Honeywell
HON
|
+$4.47M |
| 4 |
Public Storage
PSA
|
+$3.68M |
| 5 |
Boeing
BA
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Financials | 17.24% |
| 3 | Healthcare | 13.69% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Microchip Technology
MCHP
$44.2B
| $2.49M | 0.08% |
47,600
+3,200
| +7% | +$155K |
|
252
Las Vegas Sands
LVS
$30.5B
| $2.48M | 0.08% |
36,000
| – | – |
|
253
Rockwell Automation
ROK
$51.3B
| $2.43M | 0.08% |
12,000
| – | – |
|
254
Verisk Analytics
VRSK
$25.3B
| $2.43M | 0.08% |
16,300
| – | – |
|
255
Entergy
ETR
$54B
| $2.42M | 0.08% |
40,400
+1,400
| +4% | +$82.5K |
|
256
Synchrony
SYF
$23.3B
| $2.42M | 0.08% |
67,200
-3,800
| -5% | -$136K |
|
|
ALXN
257
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.38M | 0.08% |
22,000
+500
| +2% | +$53.5K |
|
258
M&T Bank
MTB
$35.6B
| $2.38M | 0.08% |
14,000
| – | – |
|
259
Realty Income
O
$60.4B
| $2.37M | 0.08% |
33,230
+1,857
| +6% | +$138K |
|
260
Royal Caribbean
RCL
$76B
| $2.35M | 0.08% |
+17,600
| New | +$2.05M |
|
261
Idexx Laboratories
IDXX
$42.5B
| $2.35M | 0.08% |
9,000
| – | – |
|
|
CERN
262
DELISTED
Cerner Corp
CERN
| $2.35M | 0.08% |
32,000
| – | – |
|
|
XLNX
263
DELISTED
Xilinx Inc
XLNX
| $2.35M | 0.08% |
24,000
| – | – |
|
264
Ameriprise Financial
AMP
$46.8B
| $2.33M | 0.08% |
14,000
| – | – |
|
265
Hartford Financial Services
HIG
$39B
| $2.31M | 0.08% |
38,000
| – | – |
|
|
FITB
266
Fifth Third Bancorp
FITB
$51.8B
| $2.31M | 0.08% |
75,000
| – | – |
|
267
Ametek
AME
$55.3B
| $2.29M | 0.08% |
23,000
-1,000
| -4% | -$94.8K |
|
268
ResMed
RMD
$27.8B
| $2.28M | 0.08% |
14,700
| – | – |
|
269
American Water Works
AWK
$26.2B
| $2.27M | 0.08% |
18,500
| – | – |
|
270
Corteva
CTVA
$59.4B
| $2.27M | 0.08% |
76,900
| – | – |
|
271
Weyerhaeuser
WY
$17B
| $2.26M | 0.08% |
75,000
| – | – |
|
272
Dollar Tree
DLTR
$22.6B
| $2.26M | 0.08% |
24,000
| – | – |
|
273
Northern Trust
NTRS
$21.9B
| $2.23M | 0.08% |
21,000
| – | – |
|
274
MSCI
MSCI
$40.2B
| $2.22M | 0.07% |
8,600
| – | – |
|
275
Hewlett Packard
HPE
$63.1B
| $2.22M | 0.07% |
140,000
| – | – |
|
Similar funds
CP
BCPE
AE
SCTC
HIM
MPW
LPC
PA
BP's Q4 2019 Portfolio in Review
As of Q4 2019, BP held 555 positions worth $2.97B, up 10% from $2.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BP's Q4 2019 filing shows 36 new, 72 increased, 56 reduced and 36 closed positions. Its largest new stake was Cummins: 15,700 shares worth $2.81M. The largest sale was Celgene Corp, an estimated $11.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- BP's largest Q4 2019 buy was Cummins: 15,700 shares worth $2.81M.
- BP added most to Bristol-Myers Squibb in Q4 2019, an estimated $11.1M increase.
- BP's biggest Q4 2019 reduction was McDonald's, cutting an estimated $5.55M.
- BP fully exited Celgene Corp in Q4 2019, selling an estimated $11.1M.
- BP's ten largest holdings make up 22% of its $2.97B portfolio in Q4 2019.
- BP opened 36 new positions and closed 36 in Q4 2019.
- BP's portfolio value rose 10% quarter-over-quarter to $2.97B.
Based on BP's 13F filing for Q4 2019, filed 7 Feb 2020.